Thymosin Beta-4 fragment
A synthetic fragment of the Thymosin Beta-4 protein, commonly discussed alongside BPC-157 in recovery contexts.
Interest is driven largely by pre-clinical and animal work on tissue repair. High-quality human trials supporting the recovery claims are lacking.
As an unapproved injectable, the practical risks are product quality and sterility, unknown dosing, and the absence of medical oversight. It is also prohibited in sport under the World Anti-Doping Code.
Not ARTG-approved. Typically sold as an unapproved "research" product, which is not lawful for human use.
No general lawful pathway for human use in Australia. It is not registered and is commonly supplied through unregulated channels that fall outside Australian law.
Yes. Thymosin Beta-4 and its fragments are prohibited at all times under the World Anti-Doping Code, which is separate from TGA regulation.
This entry is general information about TB-500, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.
This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.